Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.71T | 1.64T | 1.40T | 1.03T | 898.17B |
Gross Profit | 418.18B | 395.45B | 268.70B | 43.25B | -77.42B |
EBITDA | 353.35B | 328.61B | 245.33B | 61.27B | -72.08B |
Net Income | 113.96B | 98.76B | 88.53B | -113.20B | -233.21B |
Balance Sheet | |||||
Total Assets | 3.75T | 3.78T | 3.74T | 3.70T | 3.48T |
Cash, Cash Equivalents and Short-Term Investments | 125.62B | 233.47B | 290.17B | 319.92B | 210.31B |
Total Debt | 1.44T | 1.48T | 1.57T | 1.64T | 1.48T |
Total Liabilities | 2.47T | 2.55T | 2.59T | 2.63T | 2.52T |
Stockholders Equity | 1.16T | 1.11T | 1.03T | 968.94B | 852.91B |
Cash Flow | |||||
Free Cash Flow | 281.43B | 68.96B | 27.95B | -326.95B | -345.34B |
Operating Cash Flow | 281.43B | 318.31B | 273.96B | -86.47B | -103.30B |
Investing Cash Flow | -263.11B | -243.65B | -214.90B | -188.71B | -211.69B |
Financing Cash Flow | -126.17B | -131.62B | -88.77B | 384.69B | 446.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $62.07B | 18.74 | 24.11% | 1.98% | 0.71% | 86.84% | |
78 Outperform | $132.09B | 19.40 | 42.35% | 2.43% | 1.06% | 8.13% | |
76 Outperform | $60.42B | 20.16 | 24.83% | 1.54% | -3.27% | -10.73% | |
74 Outperform | $5.87B | 18.85 | 12.54% | 1.43% | 11.74% | 33.85% | |
74 Outperform | $33.39B | 29.15 | 10.84% | 0.49% | 3.38% | 17.21% | |
71 Outperform | $10.60B | 12.58 | 11.32% | 1.58% | 3.42% | 100.74% | |
64 Neutral | $10.95B | 16.37 | 8.81% | 1.96% | 2.68% | -15.33% |